SonarMD provides care management and patient engagement tools to help specialty practices manage complex, high‑variability patients and enable value‑based care. The company is currently deployed in inflammatory bowel disease within GI practices and positions its model for expansion into other high‑beta specialty areas. SonarMD contracts with payers to align financial incentives and works with in‑network providers to strengthen the patient‑provider relationship and continuity of care. Its approach emphasizes preventive, holistic care, reducing costly adverse events and optimizing use of expensive treatments such as specialty pharmacy medications. Leadership includes Founder and CMO Larry Kosinski, MD, and CEO Devin Gross, who signed on in August and previously led Emmi Solutions through growth to acquisition. The company says its model can lower medical and drug costs while improving patient outcomes.

Total raised

$10M

Funding rounds

1

Latest round

Series A

Latest activity

Dec 2018